Price of 137 anti-cancer drugs to fall by up to 70% as NPPA caps trade margins
The NPPA has capped trade margins on 137 non-scheduled anti-cancer drugs at 30% of MRP, which could cut prices by up to 70% from November 9, 2026.
The NPPA has capped trade margins on 137 non-scheduled anti-cancer drugs at 30% of MRP, which could cut prices by up to 70% from November 9, 2026.